Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2- breast cancer.
Max A A RagusiGonneke Ao Winter-WarnarsJelle WesselingSabine C LinnRegina G Beets-TanBas Hm van der VeldenSjoerd G EliasKenneth Ga GilhuijsClaudette E LooPublished in: The British journal of radiology (2021)
MRI characteristics previously reported to be associated with prognosis during neoadjuvant chemotherapy are not necessarily associated with prognosis during NET in ER+/HER2- breast cancer patients.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- lymph node
- contrast enhanced
- rectal cancer
- magnetic resonance imaging
- sentinel lymph node
- diffusion weighted imaging
- estrogen receptor
- endoplasmic reticulum
- squamous cell carcinoma
- breast cancer cells
- radiation therapy
- computed tomography
- magnetic resonance
- early stage
- young adults
- childhood cancer